US · Healthcare

Haw Par Corporation Limited (HAWPF)

Drug Manufacturers - General

Haw Par Corporation Limited (HAWPF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - General. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for HAWPF

P/E ratio

18.00

Haw Par Corporation Limited (HAWPF) — FAQ

What is HAWPF's P/E ratio?

The price-to-earnings (P/E) ratio for Haw Par Corporation Limited (HAWPF) is 18.00 (data as of 2026-03-24).

Does Haw Par Corporation Limited pay a dividend?

Dividend yield is not available in the current snapshot for Haw Par Corporation Limited (HAWPF). Check the MyAverix Finance app for the latest dividend data.

What sector is Haw Par Corporation Limited in?

Haw Par Corporation Limited (HAWPF) is classified in the Healthcare sector (Drug Manufacturers - General industry).

What exchange is HAWPF listed on?

HAWPF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)